Author:
Gündüz Nermin,Turgut Celaleddin
Publisher
Kocaeli Universitesi Saglik Bilimleri Dergisi
Reference15 articles.
1. Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf. 2007; 6:673–684.
2. Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K,García-Ruiz E, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005; 129:512–521.
3. Dumortier G, Cabaret W, Stamatiadis L, Saba G, Benadhira R, Rocamora JF, et al. Hepatic tolerance of atypical antipsychotic drugs. Encephale. 2002; 28:542- 551.
4. Janssen PA, Niemegeers CJ, Awouters F, Schellekens KH, Megens AA, Meert TF. Pharmacology of risperidone (R64766), a new antipsychotic with serotonin- S2 and dopamine-D2 antagonistic properties. J Pharmacol Exp Ther. 1988; 244:685–693.
5. Fang J, Bourin M, Baker GB. Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4. Naunyn Schmiedeberg’s Arch Pharmacol. 1999; 359:147–151.